GLTSCR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.17930110121733E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.19139997867279E-09 |
Normal-vs-Stage2 |
8.161600E-04 |
Normal-vs-Stage3 |
2.34550000532963E-08 |
Normal-vs-Stage4 |
1.51399999981372E-07 |
Stage1-vs-Stage2 |
9.987000E-01 |
Stage1-vs-Stage3 |
3.896400E-01 |
Stage1-vs-Stage4 |
2.561600E-01 |
Stage2-vs-Stage3 |
6.071200E-01 |
Stage2-vs-Stage4 |
4.751400E-01 |
Stage3-vs-Stage4 |
7.624800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.86960044404827E-10 |
Normal-vs-AfricanAmerican |
2.09200001766163E-09 |
Normal-vs-Asian |
4.452500E-02 |
Caucasian-vs-AfricanAmerican |
8.220500E-04 |
Caucasian-vs-Asian |
1.708760E-01 |
AfricanAmerican-vs-Asian |
4.272200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.05689950919464E-10 |
Normal-vs-Female |
6.92730317553014E-11 |
Male-vs-Female |
1.205360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.458080E-03 |
Normal-vs-Age(41-60Yrs) |
1.67199587508549E-11 |
Normal-vs-Age(61-80Yrs) |
1.89579996145994E-09 |
Normal-vs-Age(81-100Yrs) |
9.147800E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.741200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.397400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.124760E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.120200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.452400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.110500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.17880002928439E-09 |
Normal-vs-Grade 2 |
3.34819999503466E-08 |
Normal-vs-Grade 3 |
8.55429949098152E-10 |
Normal-vs-Grade 4 |
5.96539999619949E-08 |
Grade 1-vs-Grade 2 |
7.816700E-03 |
Grade 1-vs-Grade 3 |
1.692050E-02 |
Grade 1-vs-Grade 4 |
1.689650E-01 |
Grade 2-vs-Grade 3 |
3.821000E-01 |
Grade 2-vs-Grade 4 |
3.900400E-02 |
Grade 3-vs-Grade 4 |
1.460650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.52260000000548E-05 |
Normal-vs-ccB subtype |
1.26580002035581E-09 |
ccA subtype-vs-ccB subtype |
4.644900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.18290000309329E-08 |
Normal-vs-N1 |
2.540500E-03 |
N0-vs-N1 |
9.379800E-01 |
|
|